Diagonal Bio AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 0.428 million compared to SEK 0.846 million a year ago. Revenue was SEK 0.435 million compared to SEK 0.85 million a year ago. Net loss was SEK 2.53 million compared to SEK 4.19 million a year ago.
For the full year, sales was SEK 3.15 million compared to SEK 3.71 million a year ago. Revenue was SEK 3.18 million compared to SEK 3.73 million a year ago. Net loss was SEK 11.68 million compared to SEK 16.16 million a year ago.